Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ananya Banerjee

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Nanomedicine (London, England)|May 16, 2022
Antiproliferative and apoptotic potential of methotrexate lipid nanoparticles in a murine breast cancer modelChaitali Surve, Ananya Banerjee, Anupriya S, et al.
BMC Public Health|December 21, 2023
Re-assessing the social climate of physical (in)activity in CanadaMatthew James Fagan, Leigh M Vanderloo, Ananya Banerjee, et al.
Journal of Physical Activity & Health|December 28, 2023
Assessing Support for Policy Actions With Co-Benefits for Climate Change and Physical Activity in CanadaMatthew J Fagan, Leigh M Vanderloo, Ananya Banerjee, et al.
Cancers|May 14, 2022
A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal TransitionAnanya Banerjee, Shurui Cai, Guozhen Xie, et al.
The Journal of Biological Chemistry|October 14, 2011
Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-γ (PPARγ)Terry D Hinds, Lance A Stechschulte, Harrison A Cash, et al.
Canadian Journal of Diabetes|July 17, 2022
Service Provider Perspectives on Exploring Social Determinants of Health Impacting Type 2 Diabetes Management for South Asian Adults in Peel Region, CanadaChelsea D'Silva, Nuzha Hafleen, Elizabeth Mansfield, et al.
Theranostics|October 24, 2022
ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated epithelial-to-mesenchymal transitionShurui Cai, Na Li, Xuetao Bai, et al.
Molecular Cancer Therapeutics|September 20, 2019
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2<sup>-/-</sup> Ovarian Cancer CellsLu Liu, Shurui Cai, Chunhua Han, et al.
NPJ Precision Oncology|July 10, 2023
ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expressionKousalya Lavudi, Ananya Banerjee, Na Li, et al.
Cancer Research|March 22, 2019
Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian CancerAmit K Srivastava, Ananya Banerjee, Tiantian Cui, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Nanomedicine (London, England)|May 16, 2022
Antiproliferative and apoptotic potential of methotrexate lipid nanoparticles in a murine breast cancer modelChaitali Surve, Ananya Banerjee, Anupriya S, et al.
BMC Public Health|December 21, 2023
Re-assessing the social climate of physical (in)activity in CanadaMatthew James Fagan, Leigh M Vanderloo, Ananya Banerjee, et al.
Journal of Physical Activity & Health|December 28, 2023
Assessing Support for Policy Actions With Co-Benefits for Climate Change and Physical Activity in CanadaMatthew J Fagan, Leigh M Vanderloo, Ananya Banerjee, et al.
Cancers|May 14, 2022
A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal TransitionAnanya Banerjee, Shurui Cai, Guozhen Xie, et al.
The Journal of Biological Chemistry|October 14, 2011
Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-γ (PPARγ)Terry D Hinds, Lance A Stechschulte, Harrison A Cash, et al.
Canadian Journal of Diabetes|July 17, 2022
Service Provider Perspectives on Exploring Social Determinants of Health Impacting Type 2 Diabetes Management for South Asian Adults in Peel Region, CanadaChelsea D'Silva, Nuzha Hafleen, Elizabeth Mansfield, et al.
Theranostics|October 24, 2022
ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated epithelial-to-mesenchymal transitionShurui Cai, Na Li, Xuetao Bai, et al.
Molecular Cancer Therapeutics|September 20, 2019
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2<sup>-/-</sup> Ovarian Cancer CellsLu Liu, Shurui Cai, Chunhua Han, et al.
NPJ Precision Oncology|July 10, 2023
ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expressionKousalya Lavudi, Ananya Banerjee, Na Li, et al.
Cancer Research|March 22, 2019
Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian CancerAmit K Srivastava, Ananya Banerjee, Tiantian Cui, et al.
Pageof 5